Tonix Pharmaceuticals, Inc.
509 Madison Ave.
Suite 306
New York
New York
10022
United States
Tel: 212-980-9155
Fax: 212-923-5700
Website: http://www.tonixpharma.com/
304 articles with Tonix Pharmaceuticals, Inc.
-
TONIX Pharmaceuticals, Inc. Issues Letter to Shareholders
8/21/2012
-
TONIX Pharmaceuticals, Inc. CEO Dr. Seth Lederman Describes Potential Treatment for Fibromyalgia, Post-Traumatic Stress Disorder and Traumatic Brain Injury
8/16/2012
-
TONIX Pharmaceuticals, Inc. Reports That Sublingual Formulation of Fibromyalgia Drug Reduces Production of a Psychoactive Metabolite, Improving Suitability for Long-Term, Chronic Treatment
8/14/2012
-
TONIX Pharmaceuticals, Inc. Announces Completion of Clinical Trial of Sublingual TNX-102
7/30/2012
-
TONIX Pharmaceuticals, Inc. Reports Positive Preclinical Data on Sublingual TNX-102
7/9/2012
-
TONIX Pharmaceuticals, Inc. to Present at Marcum MicroCap Conference
6/19/2012
-
TONIX Pharmaceuticals, Inc. Featured on GLX-TV OpenCEOLive Series
6/14/2012
-
TONIX Pharmaceuticals, Inc. CEO Interviewed on CEOLive.TV
5/23/2012
-
TONIX Pharmaceuticals, Inc. Appoints Dr. Samuel Saks to Its Board of Directors
5/10/2012
-
TONIX Pharmaceuticals, Inc. to Present at Three Investor Conferences in May
4/30/2012
-
TONIX Pharmaceuticals, Inc. Completes Pharmacokinetic Study on New Formulation of TNX-102 for Fibromyalgia
4/6/2012
-
TONIX Pharmaceuticals, Inc. Strengthens Management Team With the Appointments of Its New Chief Financial Officer and Senior Director of Drug Development
4/4/2012
-
TONIX Pharmaceuticals, Inc. Holding Corp. Closes on Net Proceeds of $2.0 Million in Second Tranche of a $6.6 Million Private Placement
3/6/2012
-
TONIX Pharmaceuticals, Inc. to Present at the 14th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference on February 14, 2012
2/7/2012
-
TONIX Pharmaceuticals, Inc. Closes $4.3 Million Private Placement
1/23/2012
-
TONIX Pharmaceuticals, Inc. to Present at Biotech Showcase and OneMedForum Conferences in San Francisco on January 9 and 10, 2012
1/4/2012
-
TONIX Pharmaceuticals, Inc. to Present at the New York Society of Security Analysts' 15th Annual Biotech and Specialty Pharmaceuticals Conference on November 30, 2011
11/21/2011
-
TONIX Pharmaceuticals, Inc. Receives FDA Clearance to Initiate a Pharmacokinetic Study of TNX-102 for Fibromyalgia
11/18/2011
-
TONIX Pharmaceuticals, Inc. and Tamandare Explorations Announce Completion of Share Exchange Transaction and Private Placement
10/14/2011
-
TONIX Pharmaceuticals, Inc.' Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology
9/7/2011